Guidance

Reporting adverse incidents: neurostimulators

For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 1 June 2013
• Last updated: 30 December 2020 — See all updates

Documents

Adverse incidents with neurostimulators

PDF, 71.2 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Guidance on how to report adverse incidents with neurostimulators. To be read in conjunction with the guidelines on a medical devices vigilance system MEDDEV 2.12/1.

Published 1 June 2013
Last updated 30 December 2020 + show all updates

1. 30 December 2020

   This page has been updated due to the end of the transition period.

2. 1 June 2013

   First published.